Showing results (91-100 of 1,288) with videos related to
Sort By:
Pageof 129
Paediatric Drugs|September 20, 2021
Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical GuidanceGiuseppe Barone, Ailish Barry, Francisco Bautista, et al.Paediatric Drugs|September 15, 2021
Executive Function Outcome of Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Post-Hoc Analysis of Four Randomized Clinical TrialsStephen V Faraone, Roberto Gomeni, Joseph T Hull, et al.Paediatric Drugs|February 19, 2004
Drug dosing during intermittent hemodialysis and continuous renal replacement therapy : special considerations in pediatric patientsMichael A Veltri, Alicia M Neu, Barbara A Fivush, et al.Paediatric Drugs|September 29, 2004
Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategiesCarl T D'Angio, William M ManiscalcoPaediatric Drugs|May 6, 2005
Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and managementDiana Iarussi, Paolo Indolfi, Fiorina Casale, et al.Paediatric Drugs|June 16, 2006
Treatments for astrocytic tumors in children: current and emerging strategiesStanislaw R BurzynskiPaediatric Drugs|June 16, 2006
Reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed (Boostrix) US formulation): use as a single-dose booster immunization in adolescents aged 10-18 yearsJames E Frampton, Susan J KeamPaediatric Drugs|December 18, 2022
Characterization of Cardiac Function by Echocardiographic Global Longitudinal Strain in a Cohort of Children with Neurofibromatosis Type 1 Treated with SelumetinibThomas Caiffa, Antimo Tessitore, Andrea Magnolato, et al.Paediatric Drugs|December 18, 2022
Treatment Options for Juvenile Pityriasis Rubra PilarisJana Guenther, Danielle Novack, Sonia Kamath, et al.Pageof 129